Obesity in Kidney Transplantation

Journal of Renal Nutrition

Volumn 24, Issue 1, 2014, Pages 1-12

  Chan, Winnie ^a,b   Bosch, Jos A ^b   Jones, David ^c   McTernan, Philip G ^d   Phillips, Anna C ^b   Borrows, Richard ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE MODEL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; LIFESTYLE; MORTALITY; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIFE STYLE; OBESITY; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84890433686     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2013.09.002     Document Type: Review

References (80)

1. Kaplan B., Meier-Kriesche H.U. Renal transplantation: A half century of success and the long road ahead. J Am Soc Nephrol 2004, 15:3270-3271.
2. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 1999, 341:1725-1730.
3. Reimer J., Franke G., Lütkes P., et al. Quality of life in patients before and after kidney transplantation. Psychother Psychosom Med Psychol 2002, 52:16-23.
4. Machnicki G., Seriai L., Schnitzler M. Economics of transplantation: a review of the literature. Transplant Rev 2006, 20:61-75.
5. van den Ham E.C., Kooman J.P., van Hooff J.P. Nutritional considerations in renal transplant patients. Blood Purif 2002, 20:139-144.
6. Gill J., Rose C., Pereira B., Tonelli M. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007, 71:442-447.
7. Hoogeveen E.K., Aalten J., Rothman K.J., et al. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation 2011, 91:869-874.
8. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011, 11:450-462.
9. de Mattos A.M., Olyaei A.J., Bennett W.M. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 2000, 35:333-346.
10. Leeuwen MTv, Webster A.C., McCredie M.R.E., et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ 2011, 11. 340:c570.
11. Rigatto C. Management of cardiovascular disease in the renal transplant recipient. Cardiol Clin 2005, 23:331-342.
12. Kasiske B., Guijarro C., Massy Z., Wiederkehr M., Ma J. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996, 7:158-165.
13. Ojo A.O., Hanson J.A., Wolfe R.A., Leichtman A.B., Agodoa L.Y., Port F.K. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000, 57:307-313.
14. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:1-253. World Health Organization.
15. Hsu C.-Y., McCulloch C.E., Iribarren C., Darbinian J., Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006, 144:21-28.
16. Chagnac A., Herman M., Zingerman B., et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008, 23:3946-3952.
17. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006, 113:898-918.
18. Kiberd B.A. Cardiovascular disease in kidney transplant recipients. Johns Hopkins Adv Stud Med 2007, 7:169-178.
19. Soveri I., Abedini S., Holdaas H., Jardine A., Eriksson N., Fellström B. Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial. J Nephrol 2012, 25:245-254.
20. Friedman A.N., Miskulin D.C., Rosenberg I.H., Levey A.S. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003, 41:480-487.
21. Scandling J.D. Kidney transplant candidate evaluation. Semin Dial 2005, 18:487-494.
22. Holley J., Monaghan J., Byer B., Bronsther O. An examination of the renal transplant evaluation process focusing on cost and the reasons for patient exclusion. Am J Kidney Dis 1998, 32:567-574.
23. Schwarznau A., Matevossian E., Novotny A., Stangl M. Outcome of living donor renal transplantation in obese recipients. Transplant Proc 2008, 40:921-922.
24. Lynch R., Ranney D., Shijie C., Lee D., Samala N., Englesbe M. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009, 250:1014-1020.
25. Johnson D.W., Isbel N.M., Brown A.M., et al. The effect of obesity on renal transplant outcomes. Transplantation 2002, 74:675-681.
26. Bennett W.M., McEvoy K.M., Henell K.R., Valente J.F., Douzdjian V. Morbid obesity does not preclude successful renal transplantation. Clin Transplant 2004, 18:89-93.
27. Massarweh N., Clayton J., Mangum C., Florman S., Slakey D. High body mass index and short- and long-term renal allograft survival in adults. Transplantation 2005, 80:1430-1434.
28. Howard R.J., Thai V.B., Patton P.R., et al. Obese kidney transplant recipients have good outcomes. Transplant Proc 2001, 33:3420-3421.
29. Marks W.H., Florence L.S., Chapman P.H., Precht A.F., Perkinson D.T. Morbid obesity is not a contraindication to kidney transplantation. Am J Surg 2004, 187:635-638.
30. Yarlagadda S.G., Klein C.L., Jani A. Long-term renal outcomes after delayed graft function. Adv Chronic Kidney Dis 2008, 15:248-256.
31. Meier-Kriesche H.-U., Arndorfer J.A., Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002, 73:70-74.
32. Sancho A., Ávila A., Gavela E., et al. Effect of overweight on kidney transplantation outcome. Transplant Proc 2007, 39:2202-2204.
33. Gore J.L., Pham P.T., Danovitch G.M., et al. Obesity and outcome following renal transplantation. Am J Transplant 2006, 6:357-363.
34. Meier-Kriesche H.-U., Vaghela M., Thambuganipalle R., Friedman G., Jacobs M., Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation 1999, 68:1294-1297.
35. Yamamoto S., Hanley E., Hahn A.B., et al. The impact of obesity in renal transplantation: an analysis of paired cadaver kidneys. Clin Transplant 2002, 16:252-256.
36. Streja E., Molnar M.Z., Kovesdy C.P., et al. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol 2011, 6:1463-1473.
37. Schold J.D., Srinivas T.R., Guerra G., et al. A 'weight-listing' paradox for candidates of renal transplantation?. Am J Transplant 2007, 7:550-559.
38. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005, 81:543-554.
39. Modanlou K.A., Muthyala U., Xiao H., et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States Renal Data System and literature review. Transplantation 2009, 87:1167-1173.
40. Takata M.C., Campos G.M., Ciovica R., et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis 2008, 4:159-164.
41. Lin M.Y., Mehdi Tavakol M., Sarin A., et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis 2013, 9(5):653-658.
42. Johnson C.P., Gallagher-Lepak S., Zhu Y.-R., et al. Factors influencing weight gain after renal transplantation. Transplantation 1993, 56:822-826.
43. Baum C.L. Weight gain and cardiovascular risk after organ transplantation. J Parenter Enteral Nutr 2001, 25:114-119.
44. Dimeny E.M. Cardiovascular disease after renal transplantation. Kidney Int 2002, 61:S78-S84.
45. Moore L.W., Gaber A.O. Patterns of early weight change after renal transplantation. J Ren Nutr 1996, 6:21-25.
46. Teplan V., Poledne R., Schück O., Ritz E., Vítko S. Hyperlipidemia and obesity after renal transplantation. Ann Transplant 2001, 6:21-23.
47. Jaggers H.J., Allman M.A., Chan M. Changes in clinical profile and dietary considerations after renal transplantation. J Ren Nutr 1996, 6:12-20.
48. van den Ham E.C., Kooman J.P., Christiaans M.H., Leunissen K.M., van Hooff J.P. Posttransplantation weight gain is predominantly due to an increase in body fat mass. Transplantation 2000, 70:241-242.
49. van Den Ham E.C.H., Kooman J.P., Christiaans M.H.L., Nieman F.H.M., van Hooff J.P. Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Transplant Int 2003, 16:300-306.
50. Ratcliffe P.J., Dudley C.R.K., Higgins R.M., Firth J.D., Smith B., Morris P.J. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996, 348:643-648.
51. Rogers C.C., Alloway R.R., Buell J.F., et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation 2005, 80:26-33.
52. Woodle E.S., First M.R., Pirsch J., et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008, 248:564-577.
53. Elster E.A., Leeser D.B., Morrissette C., et al. Obesity following kidney transplantation and steroid avoidance immunosuppression. Clin Transplant 2008, 22:354-359.
54. van den Ham E.C.H., Kooman J.P., Christiaans M.H.L., van Hooff J.P. Relation between steroid dose, body composition and physical activity in renal transplant patients. Transplantation 2000, 69:1591-1598.
55. Armstrong K.A., Campbell S.B., Hawley C.M., Nicol D.L., Johnson D.W., Isbel N.M. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005, 5:2710-2718.
56. Kovesdy C.P., Czira M.E., Rudas A., et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 2010, 10:2644-2651.
57. Haap M., Siewecke C., Thamer C., et al. Multiple symmetric lipomatosis: A paradigm of metabolically innocent obesity?. Diabetes Care 2004, 27(3):794-795.
58. Oterdoom L.H., van Ree R.M., de Vries A.P.J., et al. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients. Transplantation 2008, 86:391-398.
59. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007, 2:219-236.
60. Abedini S., Holme I., März W., et al. Inflammation in renal transplantation. Clin J Am Soc Nephrol 2009, 4:1246-1254.
61. Axelsson J., Rashid Qureshi A., Suliman M.E., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004, 80:1222-1229.
62. Kaisar M., Armstrong K., Hawley C., et al. Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study. BMC Nephrol 2009, 10:29.
63. Chitalia N., Raja R.B., Bhandara T., et al. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. J Nephrol 2010, 23:77-84.
64. Malyszko J., Malyszko J.S., Mysliwiec M. Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients. Transplant Proc 2009, 41:150-153.
65. Malyszko J., Malyszko J.S., Pawlak K., Mysliwiec M. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant Proc 2006, 38:3434-3436.
66. Winkelmayer W.C., Schaeffner E.S., Chandraker A., et al. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transplant Int 2007, 20:505-511.
67. Lopes I.M., Martín M., Errasti P., Martínez J.A. Benefits of a dietary intervention on weight loss, body composition, and lipid profile after renal transplantation. Nutrition 1999, 15:7-10.
68. Barbagallo C., Cefalù A., Gallo S., et al. Effects of Mediterranean diet on lipid levels and cardiovascular risk in renal transplant recipients. Nephron 1999, 82:199-204.
69. Divakar D., Bailey R.R., Price M., Frampton C., George P.M. Effect of diet on posttransplant hyperlipidaemia. N Z Med J 1992, 105:79-80.
70. Stachowska E., Wesolowska T., Safranow K., et al. Simple dietary interventions reduce the risk factors of atherosclerosis in renal graft recipients. J Ren Nutr 2005, 15:291-297.
71. Shirali A.C., Bia M.J. Management of cardiovascular disease in renal transplant recipients. Clin J Am Soc Nephrol 2008, 3:491-504.
72. Patel M.G. The effect of dietary intervention on weight gains after renal transplantation. J Ren Nutr 1998, 8:137-141.
73. Orazio L.K., Isbel N.M., Armstrong K.A., et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. J Ren Nutr 2011, 21:462-471.
74. Jezior D., Krajewska M., Madziarska K., et al. Weight reduction in renal transplant recipients program: the first successes. Transplant Proc 2007, 39:2769-2771.
75. Zelle D.M., Corpeleijn E., Stolk R.P., et al. Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients. Clin J Am Soc Nephrol 2011, 6:898-905.
76. Vincenti F., Schena F.P., Paraskevas S., et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008, 8:307-316.
77. Siebenhofer A., Horvath K., Jeitler K., et al. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev 2009, 8:CD007654.
78. Evans S., Michael R., Wells H., et al. Drug interaction in a renal transplant patient: cyclosporin-neoral and orlistat. Am J Kidney Dis 2003, 41:493-496.
79. Amundsen R., Åsberg A., Robertsen I., et al. Rimonabant affects cyclosporine A, but not tacrolimus pharmacokinetics in renal transplant recipients. Transplantation 2009, 87:1221-1224.
80. Alexander J.W., Goodman H. Gastric bypass in chronic renal failure and renal transplant. Nutr Clin Pract 2007, 22:16-21.